Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Merck KGaA logo
MRK.DE
Merck KGaA
13:11:53
132.9 €
0.0000 (%0.00)
Previous Close: 133.05
Day Low₺132.4
Day High₺133.35
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

MRK.DE: Merck KGaA Financials

Merck KGaA Income Statement

Total revenue
Net income
Gross margin TTM
56.35%
Operating margin TTM
19.26%
Net profit margin TTM
12.36%
Return on investment TTM
9.12%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue21,102,000,00021,156,000,00020,993,000,00022,232,000,000
Operating income4,065,000,0004,367,000,0004,043,000,0004,996,000,000
Net income2,608,000,0002,777,000,0002,824,000,0003,325,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue21,102,000,00021,156,000,00020,993,000,00022,232,000,000
Cost of revenue9,211,000,0009,211,000,0009,324,000,0009,393,000,000
Gross profit11,891,000,00011,945,000,00011,669,000,00012,839,000,000
Research and development expenses2,382,000,0002,268,000,0002,438,000,0002,446,000,000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses5,265,000,0005,163,000,0005,017,000,0005,257,000,000
Other expenses179,000,000147,000,000171,000,000140,000,000
Operating expenses7,826,000,0007,578,000,0007,626,000,0007,843,000,000
Cost and expenses17,037,000,00016,789,000,00016,950,000,00017,236,000,000
Net interest income-181,000,000-75,000,000-102,000,000-125,000,000
Interest income81,000,000136,000,000153,000,00069,000,000
Interest expense262,000,000211,000,000255,000,000194,000,000
Depreciation and amortization1,880,000,0001,806,000,0001,782,000,0001,798,000,000
EBITDA5,450,000,0005,553,000,0005,521,000,0006,279,000,000
EBIT3,570,000,0003,747,000,0003,739,000,0004,481,000,000
Non-operating income (excl. interest)495,000,000620,000,000304,000,000515,000,000
Operating income4,065,000,0004,367,000,0004,043,000,0004,996,000,000
Total other income/expenses (net)-757,000,000-831,000,000-559,000,000-709,000,000
Income before tax3,308,000,0003,536,000,0003,484,000,0004,287,000,000
Income tax expense693,000,000750,000,000650,000,000948,000,000
Net income from continuing operations2,615,000,0002,786,000,0002,834,000,0003,339,000,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income2,608,000,0002,777,000,0002,824,000,0003,325,000,000
Net income deductions000-1,000,000
Bottom line net income2,608,000,0002,777,000,0002,824,000,0003,326,000,000
EPS6678
Diluted EPS6678
Weighted average shares outstanding434,777,878434,777,878434,777,878434,777,878
Weighted average diluted shares outstanding434,777,878434,777,878434,777,878434,777,878

Merck KGaA Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
10,205,000,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets52,100,000,00051,567,000,00048,495,000,00048,526,000,000
Total liabilities23,440,000,00021,580,000,00021,740,000,00022,521,000,000
Total equity28,592,000,00029,912,000,00026,680,000,00025,927,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents2,740,000,0002,149,000,0001,982,000,0001,398,000,000
Short-term investments597,000,000558,000,000231,000,000244,000,000
Cash and short-term investments2,740,000,0002,707,000,0002,413,000,0001,642,000,000
Net receivables4,770,000,0004,080,000,0003,976,000,0004,134,000,000
Accounts receivable4,050,000,0003,947,000,0003,976,000,0003,296,000,000
Other receivables720,000,000133,000,000105,000,000838,000,000
Inventory4,562,000,0004,484,000,0004,637,000,0004,632,000,000
Prepaid expenses182,000,000169,000,000182,000,000210,000,000
Other current assets976,000,0002,010,000,0001,185,000,0001,126,000,000
Total current assets13,230,000,00013,450,000,00012,393,000,00012,201,000,000
Property, plant and equipment (net)9,940,000,00010,025,000,0009,056,000,0008,203,000,000
Goodwill17,934,000,00019,152,000,00017,845,000,00018,415,000,000
Intangible assets7,662,000,0006,282,000,0006,551,000,0007,300,000,000
Goodwill and intangible assets25,596,000,00025,434,000,00024,396,000,00025,715,000,000
Long-term investments865,000,000557,000,000887,000,000665,000,000
Tax assets2,191,000,0001,312,000,000627,000,0001,310,000,000
Other non-current assets278,000,000788,000,0001,136,000,000432,000,000
Total non-current assets38,870,000,00038,116,000,00036,102,000,00036,325,000,000
Other assets01,000,00000
Total assets52,100,000,00051,567,000,00048,495,000,00048,526,000,000
Total payables3,001,000,0003,029,000,0003,203,000,0003,079,000,000
Accounts payable1,422,000,0001,502,000,0001,770,000,0001,596,000,000
Other payables1,579,000,0001,527,000,0001,433,000,0001,483,000,000
Accrued expenses1,275,000,0001,256,000,0001,121,000,0001,635,000,000
Short-term debt1,238,000,0003,136,000,000580,000,0001,103,000,000
Capital lease obligations (current)0137,000,000122,000,000125,000,000
Tax payables01,666,000,0001,433,000,0001,683,000,000
Deferred revenue216,000,0000249,000,000282,000,000
Other current liabilities3,312,000,0004,992,000,0003,424,000,0003,290,000,000
Total current liabilities9,042,000,00011,294,000,0008,699,000,0009,513,000,000
Long-term debt10,205,000,0006,372,000,0008,846,000,0008,834,000,000
Capital lease obligations (non-current)525,000,000625,000,000393,000,000366,000,000
Deferred revenue (non-current)2,000,0003,000,0003,000,0003,000,000
Deferred tax liabilities (non-current)1,707,000,000892,000,0001,130,000,0001,279,000,000
Other non-current liabilities1,959,000,0002,394,000,0002,669,000,0002,526,000,000
Total non-current liabilities14,398,000,00010,286,000,00013,041,000,00013,008,000,000
Other liabilities0000
Capital lease obligations525,000,000762,000,000515,000,000491,000,000
Total liabilities23,440,000,00021,580,000,00021,740,000,00022,521,000,000
Treasury stock0000
Preferred stock0000
Common stock565,000,000565,000,000565,000,000565,000,000
Retained earnings24,014,000,00022,086,000,00020,634,000,00018,463,000,000
Additional paid-in capital3,814,000,0003,814,000,0003,814,000,0003,814,000,000
Accumulated other comprehensive income/loss199,000,0003,114,000,0001,667,000,0002,737,000,000
Other stockholders' equity0000
Total stockholders' equity28,592,000,00029,912,000,00026,680,000,00025,927,000,000
Total equity28,660,000,00029,987,000,00026,755,000,00026,005,000,000
Minority interest68,000,00075,000,00075,000,00078,000,000
Total liabilities and total equity52,100,000,00051,567,000,00048,495,000,00048,526,000,000
Total investments865,000,0001,115,000,0001,118,000,000909,000,000
Total debt11,968,000,00010,271,000,0009,941,000,00010,398,000,000
Net debt9,228,000,0008,122,000,0007,959,000,0009,000,000,000

Merck KGaA Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations3,932,000,0004,586,000,0003,784,000,0004,259,000,000
Cash from investing-4,261,000,000-3,050,000,000-1,892,000,000-2,743,000,000
Cash from financing628,000,000-985,000,000-1,732,000,000-1,555,000,000
Net change in cash223,000,000535,000,000128,000,000-45,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income2,608,000,0002,786,000,0002,824,000,0003,339,000,000
Depreciation and amortization1,880,000,0002,134,000,0001,782,000,0002,030,000,000
Deferred income tax0007,000,000
Stock-based compensation002,000,000-7,000,000
Change in working capital-814,000,000-310,000,000-707,000,000-1,082,000,000
Accounts receivable-166,000,00079,000,000-8,000,000-413,000,000
Inventory-257,000,00036,000,000-89,000,000-604,000,000
Accounts payable73,000,000-178,000,000-43,000,000101,000,000
Other working capital-464,000,000-247,000,000-567,000,000-166,000,000
Other non-cash items258,000,000-24,000,000-117,000,000-28,000,000
Net cash from operating activities3,932,000,0004,586,000,0003,784,000,0004,259,000,000
Investments in property, plant and equipment-3,565,000,000-1,702,000,000-1,807,000,000-1,806,000,000
Acquisitions (net)-2,890,000,000-747,000,000-12,000,000-850,000,000
Purchases of investments00-537,000,000-364,000,000
Sales/maturities of investments415,000,0007,000,000510,000,000219,000,000
Other investing activities1,779,000,000-601,000,000-46,000,00058,000,000
Net cash from investing activities-4,261,000,000-3,050,000,000-1,892,000,000-2,743,000,000
Net debt issuance1,677,000,00053,000,000-148,000,000-589,000,000
Long-term net debt issuance562,000,000230,000,000277,000,00024,000,000
Short-term net debt issuance1,677,000,000-177,000,000-845,000,000-589,000,000
Net stock issuance0000
Net common stock issuance0000
Common stock issuance0000
Common stock repurchased0000
Net preferred stock issuance0000
Net dividends paid-1,039,000,000-284,000,000-1,152,000,000-955,000,000
Common dividends paid-1,039,000,000-284,000,000-1,152,000,000-955,000,000
Preferred dividends paid0000
Other financing activities-10,000,000-754,000,000-432,000,000-11,000,000
Net cash from financing activities628,000,000-985,000,000-1,732,000,000-1,555,000,000
Effect of FX changes on cash-76,000,000-16,000,000-31,000,000-7,000,000
Net change in cash223,000,000535,000,000128,000,000-45,000,000
Cash at end of period2,740,000,0002,517,000,0001,982,000,0001,854,000,000
Cash at beginning of period2,517,000,0001,982,000,0001,854,000,0001,899,000,000
Operating cash flow3,932,000,0004,586,000,0003,784,000,0004,259,000,000
Capital expenditure-1,584,000,000-2,184,000,000-2,023,000,000-1,806,000,000
Free cash flow2,348,000,0002,402,000,0001,761,000,0002,453,000,000
Income taxes paid0000
Interest paid0000